Telomir Pharmaceuticals, Inc. (NASDAQ: TELO) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT TELOMIR PHARMACEUTICALS, INC.

Telomir Pharmaceuticals, Inc. (NASDAQ: TELO)
Listen to this Section


$1.26
+0.0250 ( +2.03% ) 1.8K

Telomir Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells.

Market Data


Open $1.26
Previous Close $1.23
Volume 1.8K
Market Cap $84.59M
Day Range $1.24 - $1.24
52 Week Range $1.05 - $3.10
Shares Outstanding 68.78M
Change % +2.03%
Net Change ▲ 0.0250
Insider Ownership -0.24%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2024
CountryUnited States
UnderwriterKingswood Capital Markets, more

Insider Ownership Transactions

Total Amount Purchased: 49,000.00

Date Type Amount Purchased Purchaser
2024-02-15 Buy 49000.00 Bay Shore Trust

SEC Filings


Form Type Description Pages Date
8-k 8K-related 14 Nov 12, 2025
10-q Quarterly Reports 45 Nov 10, 2025
8-k 8K-related 12 Oct 22, 2025
8-k 8K-related 13 Oct 20, 2025
8-k 8K-related 12 Oct 14, 2025
8-k 8K-related 12 Oct 08, 2025
8-k 8K-related 12 Oct 06, 2025
8-k 8K-related 12 Sep 18, 2025
8-k 8K-related 12 Sep 09, 2025
8-k 8K-related 12 Sep 04, 2025

Latest News


× Before browsing our site, please accept our cookies policy